Answers are grounded in this paper and cite their sources.
Cohort study reveals frequent post-procedural tracer uptake on CXCR4 PET/CT across various healing intervals and tissue compartments, highlighting a key diagnostic pitfall.
Introduction As a pan-tumor tracer, chemokine receptor 4 (CXCR4)-directed [ 68 Ga]Ga-PentixaFor is frequently utilized in patients with hematological malignancies. We aimed to evaluate the impact of recent surgical and interventional procedures on uptake. Methods Patients undergoing [ 68 Ga]Ga-PentixaFor PET/CT after prior surgical or interventional procedures were analyzed. Uptake at the procedural site was assessed visually and quantitatively (by applying maximum standardized uptake values [SUV max ], target-to-background ratios [TBR]). Quantitative parameters were compared across anatomical region groups (bone, organ, (sub-)cutaneous, muscle). We stratified patients demonstrating uptake in procedural sites into an early (0–30 days) and late group (≥ 31 days between intervention and [ 68 Ga]Ga-PentixaFor PET). In patients with available [ 18 F]FDG PET/CT, quantitative correlation analyses between both radiotracers were also performed. Results Among 425 [ 68 Ga]Ga-PentixaFor PET/CT examinations, 87 prior invasive procedures (20.5%) were identified. In 53 patients allocated to the early group, 29 subjects demonstrated uptake (54.7%), while in the late group, 22 out of 34 subjects revealed tracer accumulation at procedural sites (64.7%). Across the predefined temporal intervals, uptake rates varied numerically but did not differ significantly overall ( p = 0.071). [ 68 Ga]Ga-PentixaFor SUV max (ρ = -0.03, p = 0.807) and TBR (ρ = 0.02, p = 0.876) showed no significant association between time since procedure. On a compartment level, SUV max ( p = 0.482) and TBR ( p = 0.696) revealed no significant differences across investigated anatomical regions. In cases with available [ 18 F]FDG PET (21/51 [41.2%]), quantitative uptake in procedural sites correlated significantly between both radiotracers (SUV max : ρ = 0.55, p = 0.016; TBR: ρ = 0.68, p = 0.001), indicating that different inflammatory signatures at procedural sites may be captured by both radiotracers. Conclusions Post-procedural CXCR4 uptake occurs frequently, with no statistically significant overall association with time since intervention or involved anatomical compartment.
No takes yet. Share an insight, caveat, or question.
Serfling et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: